These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
278 related items for PubMed ID: 32567865
1. Quantitative Proteomics Reveals the Mechanism of Silver Nanoparticles against Multidrug-Resistant Pseudomonas aeruginosa Biofilms. Zhang Y, Pan X, Liao S, Jiang C, Wang L, Tang Y, Wu G, Dai G, Chen L. J Proteome Res; 2020 Aug 07; 19(8):3109-3122. PubMed ID: 32567865 [Abstract] [Full Text] [Related]
2. Antibacterial and antibiofilm potential of silver nanoparticles against antibiotic-sensitive and multidrug-resistant Pseudomonas aeruginosa strains. de Lacerda Coriolano D, de Souza JB, Bueno EV, Medeiros SMFRDS, Cavalcanti IDL, Cavalcanti IMF. Braz J Microbiol; 2021 Mar 07; 52(1):267-278. PubMed ID: 33231865 [Abstract] [Full Text] [Related]
4. Silver nanoparticle with potential antimicrobial and antibiofilm efficiency against multiple drug resistant, extensive drug resistant Pseudomonas aeruginosa clinical isolates. Kamer AMA, El Maghraby GM, Shafik MM, Al-Madboly LA. BMC Microbiol; 2024 Jul 26; 24(1):277. PubMed ID: 39060955 [Abstract] [Full Text] [Related]
5. Combination of Silver Nanoparticles and Curcumin Nanoparticles for Enhanced Anti-biofilm Activities. Loo CY, Rohanizadeh R, Young PM, Traini D, Cavaliere R, Whitchurch CB, Lee WH. J Agric Food Chem; 2016 Mar 30; 64(12):2513-22. PubMed ID: 26595817 [Abstract] [Full Text] [Related]
6. Attenuation of biofilm and quorum sensing regulated virulence factors of an opportunistic pathogen Pseudomonas aeruginosa by phytofabricated silver nanoparticles. Rather MA, Mandal M. Microb Pathog; 2023 Dec 30; 185():106433. PubMed ID: 37913826 [Abstract] [Full Text] [Related]
7. Superior inhibition of virulence and biofilm formation of Pseudomonas aeruginosa PAO1 by phyto-synthesized silver nanoparticles through anti-quorum sensing activity. Kumar S, Paliya BS, Singh BN. Microb Pathog; 2022 Sep 30; 170():105678. PubMed ID: 35820580 [Abstract] [Full Text] [Related]
8. Potentiation of Tobramycin by Silver Nanoparticles against Pseudomonas aeruginosa Biofilms. Habash MB, Goodyear MC, Park AJ, Surette MD, Vis EC, Harris RJ, Khursigara CM. Antimicrob Agents Chemother; 2017 Nov 30; 61(11):. PubMed ID: 28848007 [Abstract] [Full Text] [Related]
9. In Vitro Antibacterial Activity of Silver Nanoparticles Conjugated with Amikacin and Combined with Hyperthermia against Drug-Resistant and Biofilm-Producing Strains. Palau M, Muñoz E, Gusta MF, Larrosa N, Gomis X, Gilabert J, Almirante B, Puntes V, Texidó R, Gavaldà J. Microbiol Spectr; 2023 Jun 15; 11(3):e0028023. PubMed ID: 37078875 [Abstract] [Full Text] [Related]
10. Antibacterial activity and mechanism of silver nanoparticles against multidrug-resistant Pseudomonas aeruginosa. Liao S, Zhang Y, Pan X, Zhu F, Jiang C, Liu Q, Cheng Z, Dai G, Wu G, Wang L, Chen L. Int J Nanomedicine; 2019 Jun 15; 14():1469-1487. PubMed ID: 30880959 [Abstract] [Full Text] [Related]
11. Synergistic effect of silver nanoparticles and polymyxin B against biofilm produced by Pseudomonas aeruginosa isolates of pus samples in vitro. Salman M, Rizwana R, Khan H, Munir I, Hamayun M, Iqbal A, Rehman A, Amin K, Ahmed G, Khan M, Khan A, Amin FU. Artif Cells Nanomed Biotechnol; 2019 Dec 15; 47(1):2465-2472. PubMed ID: 31187657 [Abstract] [Full Text] [Related]
12. Biofilm inhibition and anti-quorum sensing activity of phytosynthesized silver nanoparticles against the nosocomial pathogen Pseudomonas aeruginosa. Shah S, Gaikwad S, Nagar S, Kulshrestha S, Vaidya V, Nawani N, Pawar S. Biofouling; 2019 Jan 15; 35(1):34-49. PubMed ID: 30727758 [Abstract] [Full Text] [Related]
13. Subinhibitory Concentrations of Biogenic Silver Nanoparticles Affect Motility and Biofilm Formation in Pseudomonas aeruginosa. Saeki EK, Yamada AY, de Araujo LA, Anversa L, Garcia DO, de Souza RLB, Martins HM, Kobayashi RKT, Nakazato G. Front Cell Infect Microbiol; 2021 Jan 15; 11():656984. PubMed ID: 33869087 [Abstract] [Full Text] [Related]
14. Biosynthesis of Silver Nanoparticles Using the Biofilm Supernatant of Pseudomonas aeruginosa PA75 and Evaluation of Their Antibacterial, Antibiofilm, and Antitumor Activities. Xia F, Tao X, Wang H, Shui J, Min C, Xia Y, Li J, Tang M, Liu Z, Hu Y, Luo H, Zou M. Int J Nanomedicine; 2023 Jan 15; 18():2485-2502. PubMed ID: 37192897 [Abstract] [Full Text] [Related]
15. Crataeva nurvala nanoparticles inhibit virulence factors and biofilm formation in clinical isolates of Pseudomonas aeruginosa. Ali SG, Ansari MA, Khan HM, Jalal M, Mahdi AA, Cameotra SS. J Basic Microbiol; 2017 Mar 15; 57(3):193-203. PubMed ID: 27874198 [Abstract] [Full Text] [Related]
16. In vitro and in vivo antimicrobial activity of combined therapy of silver nanoparticles and visible blue light against Pseudomonas aeruginosa. Nour El Din S, El-Tayeb TA, Abou-Aisha K, El-Azizi M. Int J Nanomedicine; 2016 Mar 15; 11():1749-58. PubMed ID: 27175075 [Abstract] [Full Text] [Related]
17. Silver nanoparticles exert concentration-dependent influences on biofilm development and architecture. Guo J, Qin S, Wei Y, Liu S, Peng H, Li Q, Luo L, Lv M. Cell Prolif; 2019 Jul 15; 52(4):e12616. PubMed ID: 31050052 [Abstract] [Full Text] [Related]
18. Synergy of silver nanoparticles and aztreonam against Pseudomonas aeruginosa PAO1 biofilms. Habash MB, Park AJ, Vis EC, Harris RJ, Khursigara CM. Antimicrob Agents Chemother; 2014 Oct 15; 58(10):5818-30. PubMed ID: 25049240 [Abstract] [Full Text] [Related]
19. Modulation of antibiotic resistance and induction of a stress response in Pseudomonas aeruginosa by silver nanoparticles. Markowska K, Grudniak AM, Krawczyk K, Wróbel I, Wolska KI. J Med Microbiol; 2014 Jun 15; 63(Pt 6):849-854. PubMed ID: 24623636 [Abstract] [Full Text] [Related]
20. Synergistic effects of nano curcumin mediated photodynamic inactivation and nano-silver@colistin against Pseudomonas aeruginosa biofilms. Azimzadeh M, Greco G, Farmani A, Pourhajibagher M, Taherkhani A, Alikhani MY, Bahador A. Photodiagnosis Photodyn Ther; 2024 Feb 15; 45():103971. PubMed ID: 38218569 [Abstract] [Full Text] [Related] Page: [Next] [New Search]